| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Kozarich John W is a Director at LIGAND PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 29 sells.
Estimated insider holdings value: $11.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 467 | $189.58 | $88,532.49 | -0.2% | +5.0% | - | |
| Dec 1, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 467 | $195.84 | $91,456.89 | -0.2% | +2.8% | - | |
| Nov 3, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 467 | $191.05 | $89,219.01 | -0.3% | +3.5% | - | |
| Oct 1, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 467 | $179.44 | $83,800.34 | -0.3% | +6.2% | - | |
| Sep 2, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 467 | $162.26 | $75,774.85 | -0.3% | +20.3% | - | |
| Aug 1, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 467 | $131.88 | $61,585.86 | -1.0% | +40.9% | - | |
| Jul 10, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 934 | $125.00 | $116,750.00 | -2.0% | +47.6% | - | |
| May 16, 2023 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 4,444 | $77.20 | $343,080.80 | -10.4% | -13.0% | +11.2% | |
| May 8, 2023 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 6,408 | $76.56 | $490,627.88 | -7.0% | -14.4% | -5.5% | |
| Feb 28, 2022 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 908 | $102.62 | $93,178.96 | -2.2% | -12.2% | -28.7% |